世界の転移性脊椎腫瘍手術市場インサイト及び予測(低侵襲手術、開腹手術)

◆英語タイトル:Global Metastases Spinal Tumor Surgery Market Insights, Forecast to 2028

QYResearchが発行した調査報告書(QY22JLX09252)◆商品コード:QY22JLX09252
◆発行会社(リサーチ会社):QYResearch
◆発行日:2022年7月(※2025年版があります。お問い合わせください。)
◆ページ数:111
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥744,800見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,117,200見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,489,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、転移性脊椎腫瘍手術のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に転移性脊椎腫瘍手術の世界市場のxxx%を占める「低侵襲手術」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
転移性脊椎腫瘍手術の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパの転移性脊椎腫瘍手術市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

転移性脊椎腫瘍手術のグローバル主要企業には、Stryker、Johnson & Johnson、Heraeus Medical、Smith & Nephew、Medtronic、Globus Medical、DJO Global、Tecres、Merit Medical、Teknimed、G-21、OSARTIS GmbH、IZI Medicalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

転移性脊椎腫瘍手術市場は、種類と用途によって区分されます。世界の転移性脊椎腫瘍手術市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
低侵襲手術、開腹手術

【用途別セグメント】
病院、専門クリニック

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 転移性脊椎腫瘍手術製品概要
- 種類別市場(低侵襲手術、開腹手術)
- 用途別市場(病院、専門クリニック)
- 調査の目的
・エグゼクティブサマリー
- 世界の転移性脊椎腫瘍手術販売量予測2017-2028
- 世界の転移性脊椎腫瘍手術売上予測2017-2028
- 転移性脊椎腫瘍手術の地域別販売量
- 転移性脊椎腫瘍手術の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別転移性脊椎腫瘍手術販売量
- 主要メーカー別転移性脊椎腫瘍手術売上
- 主要メーカー別転移性脊椎腫瘍手術価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(低侵襲手術、開腹手術)
- 転移性脊椎腫瘍手術の種類別販売量
- 転移性脊椎腫瘍手術の種類別売上
- 転移性脊椎腫瘍手術の種類別価格
・用途別市場規模(病院、専門クリニック)
- 転移性脊椎腫瘍手術の用途別販売量
- 転移性脊椎腫瘍手術の用途別売上
- 転移性脊椎腫瘍手術の用途別価格
・北米市場
- 北米の転移性脊椎腫瘍手術市場規模(種類別、用途別)
- 主要国別の転移性脊椎腫瘍手術市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの転移性脊椎腫瘍手術市場規模(種類別、用途別)
- 主要国別の転移性脊椎腫瘍手術市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の転移性脊椎腫瘍手術市場規模(種類別、用途別)
- 主要国別の転移性脊椎腫瘍手術市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の転移性脊椎腫瘍手術市場規模(種類別、用途別)
- 主要国別の転移性脊椎腫瘍手術市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの転移性脊椎腫瘍手術市場規模(種類別、用途別)
- 主要国別の転移性脊椎腫瘍手術市場規模(トルコ、サウジアラビア)
・企業情報
Stryker、Johnson & Johnson、Heraeus Medical、Smith & Nephew、Medtronic、Globus Medical、DJO Global、Tecres、Merit Medical、Teknimed、G-21、OSARTIS GmbH、IZI Medical
・産業チェーン及び販売チャネル分析
- 転移性脊椎腫瘍手術の産業チェーン分析
- 転移性脊椎腫瘍手術の原材料
- 転移性脊椎腫瘍手術の生産プロセス
- 転移性脊椎腫瘍手術の販売及びマーケティング
- 転移性脊椎腫瘍手術の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 転移性脊椎腫瘍手術の産業動向
- 転移性脊椎腫瘍手術のマーケットドライバー
- 転移性脊椎腫瘍手術の課題
- 転移性脊椎腫瘍手術の阻害要因
・主な調査結果

Market Analysis and Insights: Global Metastases Spinal Tumor Surgery Market
The global Metastases Spinal Tumor Surgery market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Minimally Invasive Surgery accounting for % of the Metastases Spinal Tumor Surgery global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Metastases Spinal Tumor Surgery market size is valued at US$ million in 2021, while the North America and Europe Metastases Spinal Tumor Surgery are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Metastases Spinal Tumor Surgery landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metastases Spinal Tumor Surgery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metastases Spinal Tumor Surgery market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metastases Spinal Tumor Surgery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metastases Spinal Tumor Surgery market.
Global Metastases Spinal Tumor Surgery Scope and Market Size
Metastases Spinal Tumor Surgery market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Metastases Spinal Tumor Surgery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Minimally Invasive Surgery
Open Surgery
Segment by Application
Hospital
Specialty Clinic
By Company
Stryker
Johnson & Johnson
Heraeus Medical
Smith & Nephew
Medtronic
Globus Medical
DJO Global
Tecres
Merit Medical
Teknimed
G-21
OSARTIS GmbH
IZI Medical
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metastases Spinal Tumor Surgery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Minimally Invasive Surgery
1.2.3 Open Surgery
1.3 Market by Application
1.3.1 Global Metastases Spinal Tumor Surgery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Specialty Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Metastases Spinal Tumor Surgery Market Perspective (2017-2028)
2.2 Metastases Spinal Tumor Surgery Growth Trends by Region
2.2.1 Metastases Spinal Tumor Surgery Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Metastases Spinal Tumor Surgery Historic Market Size by Region (2017-2022)
2.2.3 Metastases Spinal Tumor Surgery Forecasted Market Size by Region (2023-2028)
2.3 Metastases Spinal Tumor Surgery Market Dynamics
2.3.1 Metastases Spinal Tumor Surgery Industry Trends
2.3.2 Metastases Spinal Tumor Surgery Market Drivers
2.3.3 Metastases Spinal Tumor Surgery Market Challenges
2.3.4 Metastases Spinal Tumor Surgery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Metastases Spinal Tumor Surgery Players by Revenue
3.1.1 Global Top Metastases Spinal Tumor Surgery Players by Revenue (2017-2022)
3.1.2 Global Metastases Spinal Tumor Surgery Revenue Market Share by Players (2017-2022)
3.2 Global Metastases Spinal Tumor Surgery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Metastases Spinal Tumor Surgery Revenue
3.4 Global Metastases Spinal Tumor Surgery Market Concentration Ratio
3.4.1 Global Metastases Spinal Tumor Surgery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metastases Spinal Tumor Surgery Revenue in 2021
3.5 Metastases Spinal Tumor Surgery Key Players Head office and Area Served
3.6 Key Players Metastases Spinal Tumor Surgery Product Solution and Service
3.7 Date of Enter into Metastases Spinal Tumor Surgery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Metastases Spinal Tumor Surgery Breakdown Data by Type
4.1 Global Metastases Spinal Tumor Surgery Historic Market Size by Type (2017-2022)
4.2 Global Metastases Spinal Tumor Surgery Forecasted Market Size by Type (2023-2028)
5 Metastases Spinal Tumor Surgery Breakdown Data by Application
5.1 Global Metastases Spinal Tumor Surgery Historic Market Size by Application (2017-2022)
5.2 Global Metastases Spinal Tumor Surgery Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Metastases Spinal Tumor Surgery Market Size (2017-2028)
6.2 North America Metastases Spinal Tumor Surgery Market Size by Type
6.2.1 North America Metastases Spinal Tumor Surgery Market Size by Type (2017-2022)
6.2.2 North America Metastases Spinal Tumor Surgery Market Size by Type (2023-2028)
6.2.3 North America Metastases Spinal Tumor Surgery Market Share by Type (2017-2028)
6.3 North America Metastases Spinal Tumor Surgery Market Size by Application
6.3.1 North America Metastases Spinal Tumor Surgery Market Size by Application (2017-2022)
6.3.2 North America Metastases Spinal Tumor Surgery Market Size by Application (2023-2028)
6.3.3 North America Metastases Spinal Tumor Surgery Market Share by Application (2017-2028)
6.4 North America Metastases Spinal Tumor Surgery Market Size by Country
6.4.1 North America Metastases Spinal Tumor Surgery Market Size by Country (2017-2022)
6.4.2 North America Metastases Spinal Tumor Surgery Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Metastases Spinal Tumor Surgery Market Size (2017-2028)
7.2 Europe Metastases Spinal Tumor Surgery Market Size by Type
7.2.1 Europe Metastases Spinal Tumor Surgery Market Size by Type (2017-2022)
7.2.2 Europe Metastases Spinal Tumor Surgery Market Size by Type (2023-2028)
7.2.3 Europe Metastases Spinal Tumor Surgery Market Share by Type (2017-2028)
7.3 Europe Metastases Spinal Tumor Surgery Market Size by Application
7.3.1 Europe Metastases Spinal Tumor Surgery Market Size by Application (2017-2022)
7.3.2 Europe Metastases Spinal Tumor Surgery Market Size by Application (2023-2028)
7.3.3 Europe Metastases Spinal Tumor Surgery Market Share by Application (2017-2028)
7.4 Europe Metastases Spinal Tumor Surgery Market Size by Country
7.4.1 Europe Metastases Spinal Tumor Surgery Market Size by Country (2017-2022)
7.4.2 Europe Metastases Spinal Tumor Surgery Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Metastases Spinal Tumor Surgery Market Size (2017-2028)
8.2 Asia-Pacific Metastases Spinal Tumor Surgery Market Size by Type
8.2.1 Asia-Pacific Metastases Spinal Tumor Surgery Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Metastases Spinal Tumor Surgery Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Metastases Spinal Tumor Surgery Market Share by Type (2017-2028)
8.3 Asia-Pacific Metastases Spinal Tumor Surgery Market Size by Application
8.3.1 Asia-Pacific Metastases Spinal Tumor Surgery Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Metastases Spinal Tumor Surgery Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Metastases Spinal Tumor Surgery Market Share by Application (2017-2028)
8.4 Asia-Pacific Metastases Spinal Tumor Surgery Market Size by Region
8.4.1 Asia-Pacific Metastases Spinal Tumor Surgery Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Metastases Spinal Tumor Surgery Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Metastases Spinal Tumor Surgery Market Size (2017-2028)
9.2 Latin America Metastases Spinal Tumor Surgery Market Size by Type
9.2.1 Latin America Metastases Spinal Tumor Surgery Market Size by Type (2017-2022)
9.2.2 Latin America Metastases Spinal Tumor Surgery Market Size by Type (2023-2028)
9.2.3 Latin America Metastases Spinal Tumor Surgery Market Share by Type (2017-2028)
9.3 Latin America Metastases Spinal Tumor Surgery Market Size by Application
9.3.1 Latin America Metastases Spinal Tumor Surgery Market Size by Application (2017-2022)
9.3.2 Latin America Metastases Spinal Tumor Surgery Market Size by Application (2023-2028)
9.3.3 Latin America Metastases Spinal Tumor Surgery Market Share by Application (2017-2028)
9.4 Latin America Metastases Spinal Tumor Surgery Market Size by Country
9.4.1 Latin America Metastases Spinal Tumor Surgery Market Size by Country (2017-2022)
9.4.2 Latin America Metastases Spinal Tumor Surgery Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Metastases Spinal Tumor Surgery Market Size (2017-2028)
10.2 Middle East & Africa Metastases Spinal Tumor Surgery Market Size by Type
10.2.1 Middle East & Africa Metastases Spinal Tumor Surgery Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Metastases Spinal Tumor Surgery Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Metastases Spinal Tumor Surgery Market Share by Type (2017-2028)
10.3 Middle East & Africa Metastases Spinal Tumor Surgery Market Size by Application
10.3.1 Middle East & Africa Metastases Spinal Tumor Surgery Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Metastases Spinal Tumor Surgery Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Metastases Spinal Tumor Surgery Market Share by Application (2017-2028)
10.4 Middle East & Africa Metastases Spinal Tumor Surgery Market Size by Country
10.4.1 Middle East & Africa Metastases Spinal Tumor Surgery Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Metastases Spinal Tumor Surgery Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Stryker
11.1.1 Stryker Company Details
11.1.2 Stryker Business Overview
11.1.3 Stryker Metastases Spinal Tumor Surgery Introduction
11.1.4 Stryker Revenue in Metastases Spinal Tumor Surgery Business (2017-2022)
11.1.5 Stryker Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Metastases Spinal Tumor Surgery Introduction
11.2.4 Johnson & Johnson Revenue in Metastases Spinal Tumor Surgery Business (2017-2022)
11.2.5 Johnson & Johnson Recent Developments
11.3 Heraeus Medical
11.3.1 Heraeus Medical Company Details
11.3.2 Heraeus Medical Business Overview
11.3.3 Heraeus Medical Metastases Spinal Tumor Surgery Introduction
11.3.4 Heraeus Medical Revenue in Metastases Spinal Tumor Surgery Business (2017-2022)
11.3.5 Heraeus Medical Recent Developments
11.4 Smith & Nephew
11.4.1 Smith & Nephew Company Details
11.4.2 Smith & Nephew Business Overview
11.4.3 Smith & Nephew Metastases Spinal Tumor Surgery Introduction
11.4.4 Smith & Nephew Revenue in Metastases Spinal Tumor Surgery Business (2017-2022)
11.4.5 Smith & Nephew Recent Developments
11.5 Medtronic
11.5.1 Medtronic Company Details
11.5.2 Medtronic Business Overview
11.5.3 Medtronic Metastases Spinal Tumor Surgery Introduction
11.5.4 Medtronic Revenue in Metastases Spinal Tumor Surgery Business (2017-2022)
11.5.5 Medtronic Recent Developments
11.6 Globus Medical
11.6.1 Globus Medical Company Details
11.6.2 Globus Medical Business Overview
11.6.3 Globus Medical Metastases Spinal Tumor Surgery Introduction
11.6.4 Globus Medical Revenue in Metastases Spinal Tumor Surgery Business (2017-2022)
11.6.5 Globus Medical Recent Developments
11.7 DJO Global
11.7.1 DJO Global Company Details
11.7.2 DJO Global Business Overview
11.7.3 DJO Global Metastases Spinal Tumor Surgery Introduction
11.7.4 DJO Global Revenue in Metastases Spinal Tumor Surgery Business (2017-2022)
11.7.5 DJO Global Recent Developments
11.8 Tecres
11.8.1 Tecres Company Details
11.8.2 Tecres Business Overview
11.8.3 Tecres Metastases Spinal Tumor Surgery Introduction
11.8.4 Tecres Revenue in Metastases Spinal Tumor Surgery Business (2017-2022)
11.8.5 Tecres Recent Developments
11.9 Merit Medical
11.9.1 Merit Medical Company Details
11.9.2 Merit Medical Business Overview
11.9.3 Merit Medical Metastases Spinal Tumor Surgery Introduction
11.9.4 Merit Medical Revenue in Metastases Spinal Tumor Surgery Business (2017-2022)
11.9.5 Merit Medical Recent Developments
11.10 Teknimed
11.10.1 Teknimed Company Details
11.10.2 Teknimed Business Overview
11.10.3 Teknimed Metastases Spinal Tumor Surgery Introduction
11.10.4 Teknimed Revenue in Metastases Spinal Tumor Surgery Business (2017-2022)
11.10.5 Teknimed Recent Developments
11.11 G-21
11.11.1 G-21 Company Details
11.11.2 G-21 Business Overview
11.11.3 G-21 Metastases Spinal Tumor Surgery Introduction
11.11.4 G-21 Revenue in Metastases Spinal Tumor Surgery Business (2017-2022)
11.11.5 G-21 Recent Developments
11.12 OSARTIS GmbH
11.12.1 OSARTIS GmbH Company Details
11.12.2 OSARTIS GmbH Business Overview
11.12.3 OSARTIS GmbH Metastases Spinal Tumor Surgery Introduction
11.12.4 OSARTIS GmbH Revenue in Metastases Spinal Tumor Surgery Business (2017-2022)
11.12.5 OSARTIS GmbH Recent Developments
11.13 IZI Medical
11.13.1 IZI Medical Company Details
11.13.2 IZI Medical Business Overview
11.13.3 IZI Medical Metastases Spinal Tumor Surgery Introduction
11.13.4 IZI Medical Revenue in Metastases Spinal Tumor Surgery Business (2017-2022)
11.13.5 IZI Medical Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の転移性脊椎腫瘍手術市場インサイト及び予測(低侵襲手術、開腹手術)(Global Metastases Spinal Tumor Surgery Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。